Xytis
closedBiopharmaceutical company focusing on the discovery and development of innovative central nervous system drug candidates.
Launch date
Employees
Market cap
-
Enterprise valuation
$98—147m (Dealroom.co estimates Jan 2006.)
Company register number 05116784
Irvine California (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
$24.5m | Series B | ||
| Total Funding | $24.5m | ||
Recent News about Xytis
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.